FDA approves Mesoblast’s Ryoncil for SR-aGvHD treatment
This is the only MSC therapy approved in the US for any indication.
Approvals
Yunovia receives South Korea MFDS approval for Phase I trial of GLP-1 agonist
EC conditionally approves Pfizer’s haemophilia B gene therapy
InnoCare receives clearance for leukaemia/lymphoma trial in China
FDA grants IND clearance for OKYO Pharma’s NCP treatment trial
Neurotech to begin Phase I/II trial of NTI164 for cerebral palsy
Kyverna Therapeutics given FDA approval for KYV-101 trial
Antengene gets FDA approval for Phase I trial of cancer drug
